Agreement in risk prediction between the 21-gene recurrence score assay (Oncotype DX®) and the PAM50 breast cancer intrinsic classifier ™ in early-stage estrogen receptor-positive breast cancer

Catherine M. Kelly, Philip S. Bernard, Savitri Krishnamurthy, Bailiang Wang, Mark T.W. Ebbert, Roy R.L. Bastien, Kenneth M. Boucher, Elliana Young, Takayuki Iwamoto, Lajos Pusztai

Research output: Contribution to journal › Article › peer-review

68 Scopus citations

Fingerprint

Dive into the research topics of 'Agreement in risk prediction between the 21-gene recurrence score assay (Oncotype DX®) and the PAM50 breast cancer intrinsic classifier ™ in early-stage estrogen receptor-positive breast cancer'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology